KCM Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-381
Closed -$214K 410
2026
Q1
$214K Buy
381
+4
+1% +$2.56K 0.01% 383
2025
Q4
$255K Buy
377
+19
+5% +$12.9K 0.01% 353
2025
Q3
$229K Buy
+358
New +$217K 0.01% 358
2023
Q2
Sell
-800
Closed -$400K 394
2023
Q1
$400K Buy
+800
New +$383K 0.02% 295
2022
Q3
Sell
-594
Closed -$208K 389
2022
Q2
$208K Sell
594
-162
-21% -$66.1K 0.01% 374
2022
Q1
$414K Sell
756
-1,829
-71% -$962K 0.02% 313
2021
Q4
$1.7M Sell
2,585
-6
-0.2% -$3.77K 0.06% 181
2021
Q3
$1.61M Hold
2,591
0.06% 176
2021
Q2
$1.64M Buy
2,591
+155
+6% +$85.6K 0.07% 174
2021
Q1
$1.19M Buy
2,436
+191
+9% +$95.7K 0.05% 184
2020
Q4
$1.12M Buy
2,245
+1,379
+159% +$617K 0.05% 178
2020
Q3
$340K Sell
866
-4
-0.5% -$1.48K 0.02% 259
2020
Q2
$287K Buy
870
+15
+2% +$4.34K 0.02% 283
2020
Q1
$207K Hold
855
0.01% 291
2019
Q4
$223K Sell
855
-50
-6% -$13.2K 0.01% 321
2019
Q3
$246K Sell
905
-30
-3% -$8.35K 0.01% 301
2019
Q2
$257K Hold
935
0.02% 294
2019
Q1
$209K Buy
+935
New +$193K 0.01% 306
2018
Q4
Sell
-965
Closed -$241K 490
2018
Q3
$241K Hold
965
0.01% 468
2018
Q2
$210K Buy
+965
New +$199K 0.01% 501

Other funds holding IDXX

KCM Investment Advisors's IDXX Position: Q2 2026 in Review

KCM Investment Advisors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 381 shares — an estimated $214K sold.

KCM Investment Advisors first reported a position in IDXX in Q2 2018 and held it in 20 quarters. The position peaked at $1.7M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • KCM Investment Advisors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • KCM Investment Advisors sold 381 Idexx Laboratories shares in Q2 2026, an estimated $214K.
  • KCM Investment Advisors first reported a position in Idexx Laboratories in Q2 2018 and held it in 20 quarters.
  • KCM Investment Advisors's Idexx Laboratories position peaked at $1.7M in Q4 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.